Our latest CDMO report : The majority of pharmaceutical contract manufacturers are privately owned – but for how long?

1. The majority of pharmaceutical
contract manufacturers are privately
owned – but for how long?
EY CDMO Study
The large majority of companies in today’s fragmented contract
manufacturing landscape are either privately owned, often small
family-run or mid-market companies, or assets of private equity
funds. These private companies or their assets represented the
vast majority of targets for acquisitions in the CDMO space, with
a total of 226 (56% of all CDMO deals from 2012 to 2016).
86
80
108
5
115Private strategic
Asset of investment firm
Asset of public strategic
Asset of private strategic
Public strategic
Number of dealsTarget ownership
Private strategic
Asset of investment firm
Asset of public strategic
Asset of private strategic
Public strategic
8.2
3.6
6.6
6.3
25.7
EV (US$b)Target ownership